--- title: "Baxter International (BAX) news: class action and offering" url: "https://aibio.space/companies/baxter-international/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "BAX class action, offering and merger news: Baxter faces two securities class actions and a derivative suit over Novum LVP statements." --- BAX Baxter International Inc. NYSE · United States # Baxter International (BAX) news BAX class action, offering and merger news Debt Financing · 2026-08-18 ## [Baxter raises note tender offer cap to $600 million after early results](https://aibio.space/news/baxter-raises-note-tender-offer-cap-600-million-after-early-results/) Holders tendered $756,712,000 of the 2.539% notes due 2032 by the early tender time. The offer cap rose from $500 million to $600 million. ## Latest Baxter International news 1. 2026-07-30 Legal [Baxter faces two securities class actions and a derivative suit over Novum LVP statements](https://aibio.space/news/baxter-faces-two-securities-class-actions-derivative-suit-novum-lvp/) Suits in Illinois federal court allege misleading statements about Baxter's Novum LVP pump. The 10-Q names Baxter and unnamed officers; the derivative captions name Jose E. Almeida. 2. 2026-07-30 Legal [Baxter's Hillrom unit faces Linet antitrust suit, a bed-buyer appeal and two DOJ requests](https://aibio.space/news/baxters-hillrom-unit-faces-linet-antitrust-suit-bed-buyer-appeal-two/) Linet Americas sued Hill-Rom Holdings, Hill-Rom Company and Hill-Rom Services in 2021. A dismissed class action is on appeal, and a DOJ demand and subpoena remain open. 3. 2025-12-04 Financings [Baxter closes three-series senior notes offering with about $1.99 billion in net proceeds](https://aibio.space/news/baxter-closes-three-series-senior-notes-offering-about-1-99-billion/) Baxter closed a three-series senior notes offering on December 4, 2025 and used part of the proceeds to repay its term loan. The rest is earmarked for cash tender offers on older notes, so the company is swapping debt rather than shrinking it. 4. 2025-02-03 Mergers [Baxter completes Kidney Care business sale and receives about $3.71 billion in net cash proceeds](https://aibio.space/news/baxter-completes-kidney-care-business-sale-receives-about-3-71-billion/) Baxter completed the sale of its Kidney Care business on January 31, 2025 and received about $3.71 billion in net, pre-tax cash at closing, against a $3.80 billion price set at signing. The price is still subject to post-closing adjustments, and executive Chris Toth stepped down on the closing date. ## Baxter International at a glance - **Ticker**: BAX - **Listing**: NYSE - **Country**: United States - **Cash, Sep 30, 2026**: $1.98 billion ### Related companies - [Abbott Laboratories](https://aibio.space/companies/abbott-laboratories/) NYSE: ABT - [Corbus Pharmaceuticals Holdings](https://aibio.space/companies/corbus-pharmaceuticals/) NASDAQ: CRBP - [Nexentis Technologies](https://aibio.space/companies/nexentis-technologies/) NASDAQ: NXTS - [HAEMONETICS CORP](https://aibio.space/companies/haemonetics/) NYSE: HAE - [AMERICAN SHARED HOSPITAL SERVICES](https://aibio.space/companies/american-shared-hospital-services/) NYSE: AMS - [CERUS CORP](https://aibio.space/companies/cerus/) NASDAQ: CERS - [Enzolytics](https://aibio.space/companies/enzolytics/) OTC: ENZC - [Madrigal Pharmaceuticals](https://aibio.space/companies/madrigal-pharmaceuticals/) NASDAQ: MDGL ### Also on NYSE - [WEST PHARMACEUTICAL SERVICES INC](https://aibio.space/companies/west-pharmaceutical-services/) WST - [Trulieve Cannabis](https://aibio.space/companies/trulieve-cannabis/) TRLV - [Annovis Bio](https://aibio.space/companies/annovis-bio/) ANVS - [KONINKLIJKE PHILIPS NV](https://aibio.space/companies/koninklijke-philips/) PHG - [Butterfly Network](https://aibio.space/companies/butterfly-network/) BFLY - [Warby Parker](https://aibio.space/companies/warby-parker/) WRBY ## What Baxter International does Baxter International provides essential healthcare products, including sterile intravenous solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. Its products are used in hospitals, nursing homes, ambulatory surgery centers, kidney dialysis centers, doctors' offices and at home under physician supervision. Baxter reports three segments: Medical Products & Therapies, Healthcare Systems & Technologies and Pharmaceuticals. It completed the sale of its Kidney Care business, now known as Vantive Health, to Carlyle on January 31, 2025, for an aggregate purchase price of $3.80 billion in cash. It sold its BioPharma Solutions business in 2023. Its innovation strategy focuses on connected care offerings, including smart bed systems, infusion pumps and patient monitoring, alongside core therapy products. Baxter manufactures products in over 20 countries and sells them in over 100 countries. Andrew Hider became president and chief executive officer in July 2025. | Product or program | What it is | Stage | |---|---|---| | Sterile IV solutions | Intravenous solutions used in hospitals and at home | | | Smart bed systems | Connected care beds in its Healthcare Systems & Technologies segment | | | Parenteral nutrition therapies | Nutrition therapies given by injection or infusion | | | Infusion systems and devices | Infusion pumps and administration sets | | | Generic injectable pharmaceuticals | Injectable products in the Pharmaceuticals segment | | Summarised from the company's [10-K filed Feb 12, 2026](https://www.sec.gov/Archives/edgar/data/10456/000162828026007733/bax-20251231.htm). ## Baxter International annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$11.24 billion](https://www.sec.gov/Archives/edgar/data/10456/000162828026007733/) | [$10.64 billion](https://www.sec.gov/Archives/edgar/data/10456/000162828026007733/) | | Research and development | [$518.0 million](https://www.sec.gov/Archives/edgar/data/10456/000162828026007733/) | [$590.0 million](https://www.sec.gov/Archives/edgar/data/10456/000162828026007733/) | | Net income (loss) | [-$957.0 million](https://www.sec.gov/Archives/edgar/data/10456/000162828026007733/) | [-$649.0 million](https://www.sec.gov/Archives/edgar/data/10456/000162828026007733/) | | Cash from operations | [$845.0 million](https://www.sec.gov/Archives/edgar/data/10456/000162828026007733/) | [$1.02 billion](https://www.sec.gov/Archives/edgar/data/10456/000162828026007733/) | | Cash and equivalents | [$1.97 billion](https://www.sec.gov/Archives/edgar/data/10456/000162828026068278/) | [$1.76 billion](https://www.sec.gov/Archives/edgar/data/10456/000162828026007733/) | Latest balance sheet, Sep 30, 2026 (10-Q): cash and equivalents $1.98 billion. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Baxter International Is there a class action against Baxter International? Our latest story on this, dated Jul 30, 2026: "Baxter faces two securities class actions and a derivative suit over Novum LVP statements". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/baxter-faces-two-securities-class-actions-derivative-suit-novum-lvp/). Has Baxter International raised money recently? Our latest story on this, dated Dec 4, 2025: "Baxter closes three-series senior notes offering with about $1.99 billion in net proceeds". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/baxter-closes-three-series-senior-notes-offering-about-1-99-billion/). Is Baxter International involved in a merger or acquisition? Our latest story on this, dated Aug 18, 2026: "Baxter raises note tender offer cap to $600 million after early results". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/baxter-raises-note-tender-offer-cap-600-million-after-early-results/). What is the ticker symbol of Baxter International? Baxter International Inc. trades under the ticker BAX on NYSE. Where is Baxter International listed? Baxter International Inc. is listed on NYSE. What is the SEC CIK of Baxter International? The SEC Central Index Key (CIK) for Baxter International Inc. is 10456. Its filings are on SEC EDGAR. How many shares does Baxter International have outstanding? 516,995,999 shares as of 2026-07-23, per the cover page of its 10-Q filed 2026-07-30. Which country or territory is Baxter International listed under? Our directory records Baxter International Inc. under United States. What does Baxter International do? Our directory classifies Baxter International Inc. as: Diversified pharmaceuticals/medtech. This is a directory classification, not a description of the pipeline. What is the ISIN of Baxter International? The ISIN recorded for Baxter International Inc. is US0718131099. Does aibio.space cover Baxter International? aibio.space lists Baxter International Inc. among 2,820 public biotech companies and publishes its news here as stories appear. Where is Baxter International incorporated? SEC records list its state or country of incorporation as DE. What does Baxter International develop? Baxter International provides essential healthcare products, including sterile intravenous solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. Its products are used in hospitals, nursing homes, ambulatory surgery centers, kidney dialysis centers, doctors' offices and at home under physician supervision. What is Sterile IV solutions from Baxter International? Sterile IV solutions: Intravenous solutions used in hospitals and at home What is Smart bed systems from Baxter International? Smart bed systems: Connected care beds in its Healthcare Systems & Technologies segment ## Investor discussion: Baxter International Members talk about Baxter International (BAX). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Baxter International, newest first. Each line links the filing it comes from. 1. 2026-08-04 Mergers Reported a merger or acquisition agreement. SEC Form 8-K (Items 8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/10456/000162828026052180/bax-20260804exhibit991.htm) 2. 2026-02-12 Distress Reported a leadership departure tied to a disagreement or a restructuring. SEC Form 8-K (Items 2.02,5.02,8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/10456/000162828026007474/bax-20260212xex991.htm) 3. 2026-02-12 Legal Disclosed a shareholder lawsuit, subpoena or other legal matter. SEC Form 10-K. [Source](https://www.sec.gov/Archives/edgar/data/10456/000162828026007733/bax-20251231.htm) 4. 2025-11-19 Mergers Reported a merger or acquisition agreement. SEC Form 8-K (Items 8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/10456/000162828025053056/exhibit991-8xk.htm) 5. 2025-06-12 Distress Reported the end of a material agreement. SEC Form 8-K (Items 1.01,1.02,2.03,9.01). [Source](https://www.sec.gov/Archives/edgar/data/10456/000119312525139604/d935958d8k.htm) 6. 2025-02-03 Mergers Reported completing an acquisition or a sale of assets. SEC Form 8-K (Items 2.01,5.02,9.01). [Source](https://www.sec.gov/Archives/edgar/data/10456/000162828025003388/bax-20250131.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NYSE:BAX on TradingView](https://www.tradingview.com/symbols/NYSE-BAX/). ## SEC filings and registration - **SEC name**: Baxter International Inc - **CIK**: 10456 - **Industry (SIC)**: Surgical & Medical Instruments & Apparatus (3841) - **US tickers**: BAX (NYSE) - **State or country of incorporation**: DE - **Fiscal year ends**: December 31 - **Filer category**: Large accelerated filer - **Business address**: ONE BAXTER PARKWAY, DEERFIELD, IL, 60015 - **Phone**: 2249482000 - **Shares outstanding**: 516,995,999 as of 2026-07-23 (10-Q filed 2026-07-30) ### Recent filings (8-K and 6-K are the company's own announcements) - [8-K](https://www.sec.gov/Archives/edgar/data/10456/000119312526356188/d154782d8k.htm) filed 2026-08-19 - [8-K](https://www.sec.gov/Archives/edgar/data/10456/000162828026057739/bax-20260818.htm) filed 2026-08-18 - [8-K](https://www.sec.gov/Archives/edgar/data/10456/000119312526333134/d169940d8k.htm) filed 2026-08-04 - [8-K](https://www.sec.gov/Archives/edgar/data/10456/000162828026052180/bax-20260804.htm) filed 2026-08-04 - [10-Q](https://www.sec.gov/Archives/edgar/data/10456/000162828026051118/bax-20260630.htm) filed 2026-07-30 - [8-K](https://www.sec.gov/Archives/edgar/data/10456/000162828026050795/bax-20260729.htm) filed 2026-07-30 - [8-K](https://www.sec.gov/Archives/edgar/data/10456/000162828026048158/bax-20260714.htm) filed 2026-07-14 - [8-K](https://www.sec.gov/Archives/edgar/data/10456/000119312526214680/d24051d8k.htm) filed 2026-05-08 Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000010456), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices. ## Listing details Baxter International Inc. is a public biotech or pharmaceutical company listed on NYSE under the ticker BAX, recorded under United States. The directory classifies it as Diversified pharmaceuticals/medtech. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Baxter International Inc. - **Ticker**: BAX - **Listing**: NYSE - **Country or territory**: United States - **Business scope**: Diversified pharmaceuticals/medtech - **ISIN**: US0718131099 - **Last quote in directory**: 2026-10-21 - **Directory source**: [Listing page](https://investor.baxter.com/investors/events-and-news/news/press-release-details/2026/Baxter-Reports-Second-Quarter-2026-Results/default.aspx) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/baxter-international/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Baxter International (BAX) news: class action and offering", 2026-10-31, https://aibio.space/companies/baxter-international/